Molten Ventures, one of Europe’s most well-known venture capital firms focusing on high-growth tech start-ups, has joined a Series B funding round of UK biology company Evonetix. The $24m funding round extension was led by Foresite Capital and included other early-stage investors such as Morningside, DCVC, Cambridge Consultants, Civilization Ventures and Providence. The extension brings Evonetix’s total Series B funding to $54m. This investment will be used to help bring its semiconductor chips to commercial scale. Based in Cambridge, Evonetix is developing its own silicon chip to control the synthesis of DNA.